Pre-made Votumumab benchmark antibody (Radiolabelled antibody, anti-human carcinoma associated antigen CTAA16 therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-1051

Anti-human carcinoma associated antigen CTAA16 therapeutic antibody (Pre-made Votumumab biosimilar, Radiolabelled antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m.[1] It was developed for the detection of colorectal tumors, but has never been marketed.[2]

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-1051-1mg 1mg 3090
GMP-Bios-INN-1051-10mg 10mg Inquiry
GMP-Bios-INN-1051-100mg 100mg Inquiry
GMP-Bios-INN-1051-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Votumumab Biosimilar, Radiolabelled Antibody: Anti-Human Carcinoma Associated Antigen Ctaa16 therapeutic antibody
INN Name Votumumab
Targethuman carcinoma associated antigen CTAA16
FormatRadiolabelled antibody
Derivationhuman
Species Reactivityhuman
CH1 IsotypeIgG3 - kappa
VD LCIgG3 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesOrganon Teknika Corp. (Durham NC USA) / KS Biomedix Ltd (Guildford UK)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0